Product Code: IRTNTR13347
About POC Diagnostics
POC diagnostic tests help in reducing the time between diagnosis and treatment of a disease. These tests are either antibody-based or microbial particle-based. Healthcare professionals or nurses collect the testing samples from the patient, perform analysis, and record the result. These tests include enzyme-linked immunosorbent assay (ELISA), agglutination tests, and lateral flow immunochromatography. In 2016, the global POC diagnostics market held 13.09% of the global IVD market.
Technavio's analysts forecast the global POC diagnostics market to grow at a CAGR of 7.95% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global POC diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales, volume and value of POC diagnostics.
The market is divided into the following segments based on geography:
Technavio's report, Global POC Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Alere,
- F. Hoffmann-La Roche,
- Siemens Healthineers
- Abbott
- PTS Diagnostics
- Danaher
Other Prominent Vendors
- Accriva Diagnostics
- Aesynt
- CoaguSense
- Diagon
- DiaSys
- EKF Diagnostics
- Epistem
- FUJIFILM
- Helena Laboratories
- HemoSonics
- iLine Microsystems
- Jant Pharmacal
- LifeScan
- Micropoint Bioscience
- Nova Biomedical
- Philips healthcare
- PixCell
- Quidel
- Radisens Diagnostics
- Securetec
- Detektions-Systeme
- Sysmex
- TaiDoc
Market driver
- Growing focus on diagnosing life-threatening conditions
- For a full, detailed list, view our report
Market challenge
- Lack of skilled professionals to carry out POC diagnosis
- For a full, detailed list, view our report
Market trend
- Emerging technology of molecular diagnosis in POC
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Market segmentation by product
- Market overview
- Global POC blood glucose diagnostics market
- Global POC HbA1c diagnostics market
- Global POC rapid cardiovascular diagnostics market
- Global POC blood gas and electrolyte diagnostics market
- Global POC infectious disease diagnostics market
- Global POC rapid coagulation diagnostics market
- Global POC Hematology diagnostics market
- Global POC pregnancy diagnostics market
- Global POC urinalysis market
- Global POC lipid testing market
- Global POC drug of abuse diagnostics market
- Global POC fecal occult testing market
PART 07: Market segmentation by end-user
- Market overview
- Hospitals and clinics
- Clinical diagnostic laboratories
- Home care settings
- Buying criteria analysis: Global POC Diagnostics market by end-users 2016
PART 08: Geographical segmentation
- Market overview
- Global POC diagnostic market in Americas
- Global POC diagnostic market in EMEA
- Global POC diagnostic market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
- Market drivers
- Market challenges
PART 11: Market trends
- Focus on next-generation technologies
- Increasing online marketing services for POC diagnosis
- Data management and connectivity to EHRs through interoperability
PART 12: Vendor landscape
PART 13: Key vendor analysis
- Alere
- F. Hoffmann-La Roche
- Siemens Healthineers
- Danaher
- Key companies to watch
- Other prominent vendors
PART 14: Appendix
List of Exhibits
- Exhibit 01: Market overview of global IVD and POC diagnostics market 2016
- Exhibit 02: Market outline of global POC diagnostics market 2016
- Exhibit 03: Global POC diagnostics market ($ millions)
- Exhibit 04: Five forces analysis
- Exhibit 05: Segment life cycle of POC diagnostics market in 2016
- Exhibit 06: POC diagnostic market segmentation by product
- Exhibit 07: Global POC diagnostics blood glucose market 2016-2021 ($ millions)
- Exhibit 08: Market metric analysis: POC blood glucose diagnostics market 2016
- Exhibit 09: Global POC HbA1c diagnostics market 2016-2021 ($ millions)
- Exhibit 10: Market metric analysis: POC HbA1c diagnostics market 2016
- Exhibit 11: Global POC rapid cardiovascular diagnostics market 2016-2021 ($ millions)
- Exhibit 12: Market metric analysis: Global POC rapid cardiovascular diagnostics market 2016
- Exhibit 13: Global POC blood gas and electrolyte diagnostics market 2016-2021 ($ millions)
- Exhibit 14: Market metric analysis: Global POC blood gas and electrolyte diagnostics market 2016
- Exhibit 15: Global POC infectious disease diagnostics market 2016-2021 ($ millions)
- Exhibit 16: Increased prevalence of Hepatitis in US 2015
- Exhibit 17: Market metric analysis: Global POC infectious disease diagnostics market 2016
- Exhibit 18: Global POC rapid coagulation diagnostics market 2016-2021 ($ millions)
- Exhibit 19: Market metric analysis: Global POC rapid coagulation diagnostics market 2016
- Exhibit 20: Global POC hematology diagnostics market 2016-2021 ($ millions)
- Exhibit 21: Market metric analysis: Global POC hematology diagnostics market 2016
- Exhibit 22: Global POC pregnancy diagnostics market 2016-2021 ($ millions)
- Exhibit 23: Market metric analysis: Global POC pregnancy diagnostics market 2016
- Exhibit 24: Global POC urinalysis market 2016-2021 ($ millions)
- Exhibit 25: Market metric analysis: Global POC urinalysis market 2016
- Exhibit 26: Global POC lipid testing market 2016-2021 ($ millions)
- Exhibit 27: Market metric analysis: Global POC lipid testing market 2016
- Exhibit 28: Global POC drug of abuse diagnostics market 2016-2021 ($ millions)
- Exhibit 29: Market metric analysis: Global POC drug of abuse diagnostics market 2016
- Exhibit 30: Global POC fecal occult testing market 2016-2021 ($ millions)
- Exhibit 31: Market metric analysis: Global POC fecal occult testing market 2016
- Exhibit 32: Global POC diagnostic market segmentation by end-users 2016
- Exhibit 33: Marketing strategy analysis of global POC diagnostics market by end-users 2016
- Exhibit 34: Market overview by hospitals and clinics 2016
- Exhibit 35: Market overview by clinical diagnostic laboratories 2016
- Exhibit 36: Market overview by home care settings 2016
- Exhibit 37: Global POC diagnostics market segmentation by geography 2016 and 2021 ($ millions)
- Exhibit 38: Market overview: POC diagnostics market in Americas 2016-2021
- Exhibit 39: Global POC diagnostics market in Americas ($ millions)
- Exhibit 40: The Americas: Market metrics in various countries
- Exhibit 41: Market overview: POC diagnostics market in EMEA (2016-2021)
- Exhibit 42: Global POC diagnostics market in EMEA ($ millions)
- Exhibit 43: Market overview: POC diagnostics market in APAC 2016-2021
- Exhibit 44: Global POC diagnostics market in APAC ($ millions)
- Exhibit 45: Global increasing percentage of older adult population 2015-2030
- Exhibit 28: Favorable reimbursements by Abbott's cartridge in POCT for end-users in US
- Exhibit 46: Complete list of products recalled by Alere in 2016
- Exhibit 47: Competitive structure analysis of global POC diagnostics market 2016
- Exhibit 48: Market penetration of various global POC diagnostic market providers 2017
- Exhibit 49: Strategic success factors of companies in global POC diagnostic market 2017
- Exhibit 50: Alere: Strength assessment
- Exhibit 51: Alere: Strategy assessment
- Exhibit 52: Alere: Opportunity assessment
- Exhibit 53: F. Hoffmann-La Roche: Strength assessment
- Exhibit 54: F. Hoffmann-La Roche: Strategy assessment
- Exhibit 55: F. Hoffmann-La Roche: Opportunity assessment
- Exhibit 56: Siemens Healthineers: Strength assessment
- Exhibit 57: Siemens Healthineers: Strategy assessment
- Exhibit 58: Siemens Healthineers: Opportunity assessment
- Exhibit 59: Danaher: Key highlights
- Exhibit 60: Danaher: Strength assessment
- Exhibit 61: Danaher: Strategy assessment
- Exhibit 62: Danaher: Opportunity assessment
- Exhibit 63: Abbott: Company assessment
- Exhibit 64: PTS diagnostics: Company assessment
